Novel coronavirus infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who signed informed consent forms; 2. Non-icu inpatients who were assessed for immune function within 48 hours after admission; 3. The age is above 18 and below 90; 4. Mild/medium patients diagnosed with COVID-19 infection.
Exclusion criteria
Exclusion criteria: 1. Pregnant woman; 2. Patients with autoimmune diseases, severe hepatitis, blood diseases, congenital immune deficiency syndrome and other immune function abnormalities; 3. Patients who were being treated with immunosuppressive immunomodulators and immunosuppressive doses of corticosteroids prior to admission; 4. Patients who refused to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether to be transferred to serious condition;Hospitalization cost; | — |
Secondary
| Measure | Time frame |
|---|---|
| Whether there is secondary bacterial infection;Whether to be transferred to ICU for treatment;Length of stay; | — |
Countries
China
Contacts
Affiliated Hospital of Jiangsu University